Castle Biosciences Inc (NAS:CSTL) Stock News, Headlines & Updates
Castle Biosciences Inc Stock News from GuruFocus
- 1
- 2
Jun 27, 2025
Castle Biosciences Inc (CSTL) Trading 3.67% Higher on Jun 27
GuruFocus News • 12:10pm
Jun 19, 2025
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | CSTL Stock News
GuruFocus News • 6:17am
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 6:00am
Jun 17, 2025
Castle Biosciences Inc (CSTL) Stock Price Down 4.54% on Jun 17
GuruFocus News • 12:13pm
Jun 16, 2025
Castle Biosciences Enters Collaboration and License Agreement with SciBase to Develop Diagnostic Tests for Dermatologic Diseases
Marketwired • 4:00pm
Castle Biosciences Enters Collaboration and License Agreement with SciBase to Develop Diagnostic Tests for Dermatologic Diseases | CSTL Stock News
GuruFocus News • 3:47pm
Castle Biosciences (CSTL) Partners with SciBase for Dermatology Advancements | CSTL Stock News
GuruFocus News • 3:47pm
Jun 11, 2025
Castle Biosciences' Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention | CSTL Stock News
GuruFocus News • 6:21am
Castle Biosciences' Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention
Marketwired • 6:00am
Jun 10, 2025
Virtual Meeting Scheduled for CSTL by Lake Street | CSTL Stock News
GuruFocus News • 9:45am
Jun 04, 2025
Castle Biosciences' Founder, President and CEO Derek Maetzold Honored with Prestigious Lifetime Achievement Award by The American Business Awards®
Marketwired • 6:00am
Jun 02, 2025
CSTL to Join KeyBanc's New York Dinner Meeting for Investors | CSTL Stock News
GuruFocus News • 4:15pm
May 29, 2025
New Data at ASCO 2025 Affirms DecisionDx®-Melanoma's Ability to Improve Upon Staging-Based Risk Stratification and Predict Survival Outcomes
Marketwired • 4:00pm
New Data at ASCO 2025 Affirms DecisionDx®-Melanoma's Ability to Improve Upon Staging-Based Risk Stratification and Predict Survival Outcomes | CSTL Stock News
GuruFocus News • 3:48pm
May 21, 2025
Castle Biosciences (CSTL) Target Price Updated by Scotiabank | CSTL Stock News
GuruFocus News • 11:01am
Castle Biosciences (CSTL) Price Target Revised by Scotiabank | CSTL Stock News
GuruFocus News • 9:45am
Castle Biosciences to Present at the 2025 Jefferies Global Healthcare Conference | CSTL Stock News
GuruFocus News • 6:20am
Castle Biosciences to Present at the 2025 Jefferies Global Healthcare Conference
Marketwired • 6:00am
May 09, 2025
Castle Biosciences (CSTL) Presents New Data on Uveal Melanoma Risk Prediction | CSTL Stock News
GuruFocus News • 6:46am
Real-World Study Confirms Long-Term Performance of DecisionDx®-UM for Metastatic Risk Stratification in Uveal Melanoma and Utility of PRAME Biomarker for Refining Risk When Considered with the Decisio
GuruFocus News • 6:21am
May 07, 2025
Castle Biosciences (CSTL) Champions Skin Cancer Awareness Initiatives | CSTL Stock News
GuruFocus News • 7:11am
Castle Biosciences Celebrates Skin Cancer Awareness Month
Marketwired • 6:00am
May 06, 2025
Castle Biosciences (CSTL) Rating Maintained as Price Target Lowered | CSTL Stock News
GuruFocus News • 6:31pm
Castle Biosciences (CSTL) Reports Strong Q1 2025 Revenue Growth
GuruFocus News • 12:58pm
Castle Biosciences (CSTL) Target Price Reduced Despite Strong Revenue Report | CSTL Stock News
GuruFocus News • 8:01am
Castle Biosciences (CSTL) Receives Price Target Adjustment by Canaccord Genuity | CSTL Stock News
GuruFocus News • 7:01am
Canaccord Adjusts Price Target for Castle Biosciences (CSTL) | CSTL Stock News
GuruFocus News • 6:18am
Castle Biosciences Inc (CSTL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Operational Challenges
GuruFocus News • 1:07am
Q1 2025 Castle Biosciences Inc Earnings Call Transcript
GuruFocus News • 11:01pm
May 05, 2025
Castle Biosciences (CSTL) to Acquire Gastrointestinal Firm Previse | CSTL Stock News
GuruFocus News • 4:46pm
Castle Biosciences (CSTL) Adjusts 2025 Revenue Outlook | CSTL Stock News
GuruFocus News • 4:15pm
Castle Biosciences (CSTL) Exceeds Revenue Expectations in Q1 | CSTL Stock News
GuruFocus News • 4:15pm
Castle Biosciences Reports First Quarter 2025 Results
Marketwired • 4:00pm
Castle Biosciences to Acquire Previse
Marketwired • 4:00pm
Castle Biosciences Inc (CSTL) Reports Q1 2025 Revenue of $88M, Beating Estimates; EPS Falls Short at $(0.90)
GuruFocus News • 3:48pm
Castle Biosciences to Acquire Previse | CSTL Stock News
GuruFocus News • 3:20pm
Castle Biosciences Reports First Quarter 2025 Results | CSTL Stock News
GuruFocus News • 3:17pm
May 02, 2025
New Data at DDW 2025 Further Demonstrates the TissueCypher® Test's Ability to Identify Patients at Increased Risk for Developing Esophageal Cancer
Marketwired • 4:00pm
New Data at DDW 2025 Further Demonstrates the TissueCypher® Test's Ability to Identify Patients at Increased Risk for Developing Esophageal Cancer | CSTL Stock News
GuruFocus News • 3:47pm
Castle Biosciences Inc (CSTL) Q1 2025 Earnings Report Preview: What To Expect
GuruFocus News • 7:30am
- 1
- 2
Show
Entries
Headlines
Total 0- 1
No recent news